Endothelium‐dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin‐induced diabetic rats
- 1 October 1992
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 107 (2) , 393-399
- https://doi.org/10.1111/j.1476-5381.1992.tb12757.x
Abstract
1. Noradrenaline sensitivity and acetylcholine-induced relaxation were investigated in mesenteric resistance arteries of control and streptozotocin-induced diabetic rats. 2. The diabetic rats demonstrated enhanced vascular sensitivity to noradrenaline compared with age-matched controls (pEC50 5.99 +/- 0.06 for diabetic rats, n = 25, versus 5.82 +/- 0.03 for controls, n = 45, P < 0.05). 3. Significant impairment of acetylcholine-induced relaxation was observed in arteries from the diabetic animals compared with controls (pEC50 6.81 +/- 0.17 for diabetic rats, n = 21, versus 7.54 +/- 0.17 for controls, n = 45, P < 0.001). 4. The difference between acetylcholine-induced relaxation in diabetic and control arteries remained in the presence of 10 microM indomethacin (pEC50 6.41 +/- 0.11 for diabetic rats, n = 16, versus 7.59 +/- 0.08 for controls, n = 20, P < 0.001). 5. The nitric oxide synthase inhibitor, NG-monomethyl-L-arginine (L-NMMA, 1 mM) produced profound inhibition of acetylcholine-induced relaxation in diabetic arteries but partial inhibition in controls. The incomplete inhibition of acetylcholine-induced relaxation by L-NMMA in the control arteries was the result of ineffective inhibition of nitric oxide synthase since an alternative inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 0.1 mM), led to similar inhibition to that seen in the diabetic arteries with L-NMMA. The endothelium-derived relaxing factor (EDRF)-mediated component of acetylcholine-induced relaxation determined by use of the nitric oxide synthase inhibitors was, therefore, apparently reduced in diabetic rats compared with control animals.6. In further experiments L-NAME was found to enhance the response to noradrenaline in control rats but not in diabetic animals, suggesting that the abnormal response to noradrenaline in the diabetic animals was also due to reduced EDRF release.7. Nitroprusside-induced relaxation (endothelium-independent) was similar in arteries from control anddiabetic rats (pEC5o 7.61 +/- 0.13 for diabetic arteries, n = 18, versus 7.68 +/- 0.15 in the controls, n = 20, P not significant).8. These results suggest that endothelial function is abnormal in mesenteric resistance arteries of streptozotocin-induced diabetic rats and that this is predominantly due to reduced EDRF release.Keywords
This publication has 39 references indexed in Scilit:
- Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.Hypertension, 1990
- Differences in vascular responses to vasoactive agents of basilar artery and aorta from rabbits with alloxan-induced diabetesCanadian Journal of Physiology and Pharmacology, 1990
- Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta.Journal of Clinical Investigation, 1990
- Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginineBiochemical and Biophysical Research Communications, 1990
- Histamine relaxation of aortic rings from diabetic ratsInflammation Research, 1989
- Impaired Neurogenic and Endothelium-Mediated Relaxation of Penile Smooth Muscle from Diabetic Men with ImpotenceNew England Journal of Medicine, 1989
- Altered Responsiveness of Diabetic Dog Renal Arteries to Acetylcholine and Phenylephrine: Role of EndotheliumPharmacology, 1989
- Modulation of vascular tonus by the endothelium in experimental diabetesLife Sciences, 1987
- The influence of chronic experimental diabetes on contractile responses of rat isolated blood vesselsCanadian Journal of Physiology and Pharmacology, 1985
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980